Announcement on behalf of Broadsound Corporation for the board of directors resolved to convene the annual general shareholders meeting in 2022
· Issued by AmCad BioMed Corporation
Close
Today's Information
Provided by: AmCad BioMed Corporation
SEQ_NO
3
Date of announcement
2022/02/10
Time of announcement
17:47:23
Subject
Announcement on behalf of Broadsound Corporation
for the board of directors resolved to convene the
annual general shareholders meeting in 2022
Date of events
2022/02/10
To which item it meets
paragraph 17
Statement
1.Date of the board of directors resolution:2022/02/10
2.General shareholders' meeting date:2022/06/09
3.General shareholders' meeting location:
5F., No. 167, Fuxing N. Rd., Songshan Dist., Taipei City
4.Cause for convening the meeting I.Reported matters:
(I) To report the business of 2021.
(II) Supervisors review 2021 Financial Statements.
5.Cause for convening the meeting II.Acknowledged matters:
(I) To accept 2021 Business Report and Financial Statements
(II) To accept the proposal for loss off-setting of 2021,
and in the case of capital reserves to make up for the accumulated losses
6.Cause for convening the meeting III, Matters for Discussion:None
7.Cause for convening the meeting IV.Election matters:None
8.Cause for convening the meeting V.Other Proposals:None
9.Cause for convening the meeting VI.Extemporary Motions:None
10.Book closure starting date:2022/05/11
11.Book closure ending date:2022/06/09
12.Any other matters that need to be specified:
The time frame for the acceptance of proposed resolutions from eligible
shareholders, who holds shares more than 1%, will start from February 25
to March 5, 2022 in accordance with the Company Act Article 172-1.
